ID   JR1neo20
AC   CVCL_A8SI
DR   Wikidata; Q108820563
RX   PubMed=10933967;
RX   PubMed=11306486;
CC   Characteristics: Control cell line for JR1Nmyc6 (Cellosaurus=CVCL_A8SJ) and JR1Nmyc9 (Cellosaurus=CVCL_A8SK) (PubMed=10933967).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J063 ! JR-1
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
RX   PubMed=10933967; DOI=10.1006/mthe.2000.0064;
RA   Pawlik C.A., Iyengar R.V., Krull E.J., Mason S.E., Khanna R.,
RA   Harris L.C., Potter P.M., Danks M.K., Guichard S.M.;
RT   "Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated
RT   overexpression of a rabbit carboxylesterase to sensitize neuroblastoma
RT   cells to CPT-11.";
RL   Mol. Ther. 1:457-463(2000).
//
RX   PubMed=11306486;
RA   Iyengar R.V., Pawlik C.A., Krull E.J., Phelps D.A., Burger R.A.,
RA   Harris L.C., Potter P.M., Danks M.K.;
RT   "Use of a modified ornithine decarboxylase promoter to achieve
RT   efficient c-MYC- or N-MYC-regulated protein expression.";
RL   Cancer Res. 61:3045-3052(2001).
//